Ruth Percik

985 total citations
31 papers, 618 citations indexed

About

Ruth Percik is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Ruth Percik has authored 31 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Epidemiology and 8 papers in Neurology. Recurrent topics in Ruth Percik's work include Cancer Immunotherapy and Biomarkers (10 papers), Neuroblastoma Research and Treatments (8 papers) and Neuroendocrine Tumor Research Advances (6 papers). Ruth Percik is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Neuroblastoma Research and Treatments (8 papers) and Neuroendocrine Tumor Research Advances (6 papers). Ruth Percik collaborates with scholars based in Israel, Russia and United States. Ruth Percik's co-authors include Michael Stümvoll, Amir Tirosh, Ehud Grossman, Annette Horstmann, Raya Leibowitz‐Amit, Haiko Schloegl, Arno Villringer, Nir Ayalon, Eyal Meltzer and Eli Schwartz and has published in prestigious journals such as The Lancet Oncology, Hypertension and European Heart Journal.

In The Last Decade

Ruth Percik

29 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Percik Israel 13 196 130 93 85 85 31 618
Gürsel Acartürk Türkiye 13 171 0.9× 86 0.7× 42 0.5× 140 1.6× 49 0.6× 35 686
Yuqian Bao China 13 44 0.2× 60 0.5× 48 0.5× 91 1.1× 156 1.8× 52 475
Ping Zhu China 13 84 0.4× 104 0.8× 18 0.2× 64 0.8× 85 1.0× 47 502
Cansel Türkay Türkiye 19 115 0.6× 71 0.5× 40 0.4× 288 3.4× 68 0.8× 50 825
Marina Ivanišević Croatia 19 37 0.2× 49 0.4× 171 1.8× 102 1.2× 224 2.6× 84 1.2k
Jie Shi China 11 46 0.2× 77 0.6× 72 0.8× 120 1.4× 68 0.8× 37 582
Mehmet Yılmazer Türkiye 18 52 0.3× 98 0.8× 358 3.8× 71 0.8× 105 1.2× 78 1.1k
Weihua Chen China 12 39 0.2× 111 0.9× 30 0.3× 168 2.0× 83 1.0× 47 546
M Guftar Shaikh United Kingdom 15 68 0.3× 48 0.4× 65 0.7× 79 0.9× 331 3.9× 57 954
Tamer Hassan Egypt 15 49 0.3× 25 0.2× 67 0.7× 55 0.6× 33 0.4× 58 648

Countries citing papers authored by Ruth Percik

Since Specialization
Citations

This map shows the geographic impact of Ruth Percik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Percik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Percik more than expected).

Fields of papers citing papers by Ruth Percik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Percik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Percik. The network helps show where Ruth Percik may publish in the future.

Co-authorship network of co-authors of Ruth Percik

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Percik. A scholar is included among the top collaborators of Ruth Percik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Percik. Ruth Percik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Percik, Ruth, Shiraz Vered, & Yair Liel. (2025). Incidence, Temporal Trends, and Socioeconomic Aspects of Acquired Male Hypogonadism. Experimental and Clinical Endocrinology & Diabetes. 133(5). 228–234.
2.
Percik, Ruth, et al.. (2023). Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience. Biologics. Volume 17. 61–67. 2 indexed citations
3.
4.
Parikh, Roma, Shivang Parikh, Rina Hemi, et al.. (2023). Seasonal AMH variability implies a positive effect of UV exposure on the deterioration of ovarian follicles. Steroids. 200. 109307–109307. 3 indexed citations
5.
Tankova, Tsvetalina, Elżbieta Senkus, Simona Borštnar, et al.. (2022). Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer. Cancers. 14(7). 1598–1598. 30 indexed citations
6.
7.
Luria, Mijal, et al.. (2022). Sexual dysfunction among adolescent and young adult cancer patients: diagnostic and therapeutic approach. Current Opinion in Supportive and Palliative Care. 16(2). 83–91. 4 indexed citations
8.
Percik, Ruth, et al.. (2021). Plasma Hemoglobin and Red Blood Cell Mass Levels as Dynamic Prognostic Markers for Progression and Survival in Pancreatic Neuroendocrine Tumors. Hormone and Metabolic Research. 53(12). 810–817. 4 indexed citations
9.
Percik, Ruth, James Larkin, & Daniel L. Morganstein. (2021). Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis. The Lancet Oncology. 22(7). 905–907. 4 indexed citations
10.
Percik, Ruth, et al.. (2021). Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity. Endocrine Practice. 27(2). 101–109. 30 indexed citations
11.
Fardman, Alexander, Ruth Percik, Shlomo Segev, et al.. (2020). Cardiorespiratory Fitness Is an Independent Predictor of Cardiovascular Morbidity and Mortality and Improves Accuracy of Prediction Models. Canadian Journal of Cardiology. 37(2). 241–250. 20 indexed citations
12.
Percik, Ruth & Yehuda Shoenfeld. (2020). Check point inhibitors and autoimmunity: Why endocrinopathies and who is prone to?. Best Practice & Research Clinical Endocrinology & Metabolism. 34(1). 101411–101411. 16 indexed citations
13.
Golan, Tamar, Roma Parikh, Etai Jacob, et al.. (2019). Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211. Science Signaling. 12(591). 23 indexed citations
14.
Percik, Ruth, Gadi Shlomai, Amir Tirosh, et al.. (2019). Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors. Autoimmunity Reviews. 19(2). 102454–102454. 43 indexed citations
15.
Percik, Ruth, et al.. (2019). Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide. Endocrine. 65(2). 393–398. 6 indexed citations
16.
Bar, Jair, Gal Markel, Teodor Gottfried, et al.. (2019). Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study. European Journal of Cancer. 120. 122–131. 84 indexed citations
17.
Percik, Ruth, et al.. (2019). Anatomic site as prognostic marker of pancreatic neuroendocrine tumors: a cohort study. European Journal of Endocrinology. 181(3). 325–330. 7 indexed citations
18.
Percik, Ruth, et al.. (2018). A pilot study of a novel therapeutic approach to obesity: CNS modification by N.I.R. H.E.G. neurofeedback. Clinical Nutrition. 38(1). 258–263. 7 indexed citations
19.
Schloegl, Haiko, Ruth Percik, Annette Horstmann, Arno Villringer, & Michael Stümvoll. (2010). Peptide hormones regulating appetite—focus on neuroimaging studies in humans. Diabetes/Metabolism Research and Reviews. 27(2). 104–112. 50 indexed citations
20.
Percik, Ruth & Michael Stümvoll. (2009). Obesity and Cancer. Experimental and Clinical Endocrinology & Diabetes. 117(10). 563–566. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gürsel Acartürk Breakdown of academic impact, for papers by Yuqian Bao Breakdown of academic impact, for papers by Ping Zhu Breakdown of academic impact, for papers by Cansel Türkay Breakdown of academic impact, for papers by Marina Ivanišević Breakdown of academic impact, for papers by Jie Shi Breakdown of academic impact, for papers by Mehmet Yılmazer Breakdown of academic impact, for papers by Weihua Chen Breakdown of academic impact, for papers by M Guftar Shaikh Breakdown of academic impact, for papers by Tamer Hassan
Rankless by CCL
2026